| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JNCI/DJV307 |
| P698 | PubMed publication ID | 26563356 |
| P2093 | author name string | Siraj M Ali | |
| Vincent A Miller | |||
| Philip J Stephens | |||
| Jeffrey S Ross | |||
| Victor Wong | |||
| John Crawford | |||
| Roman Yelensky | |||
| Dean Pavlick | |||
| Tim Brennan | |||
| Hyunah Ahn | |||
| Denise Malicki | |||
| P2860 | cites work | Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer. | Q27852601 |
| Infantile fibrosarcoma: management based on the European experience. | Q33516050 | ||
| Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma | Q34754714 | ||
| Congenital-infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues | Q38462062 | ||
| Chaperones as thermodynamic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells | Q41813875 | ||
| Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing | Q47163678 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | crizotinib | Q5186964 |
| comprehensive genomic profiling | Q114107212 | ||
| P577 | publication date | 2015-11-12 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib. | |
| P478 | volume | 108 |
| Q57055324 | A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes |
| Q58720733 | A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-NTRK1 gene fusion with durable clinical response to crizotinib: a case report |
| Q38891711 | Causes and consequences of nuclear envelope alterations in tumour progression |
| Q55003763 | Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor. |
| Q36257816 | FuGePrior: A novel gene fusion prioritization algorithm based on accurate fusion structure analysis in cancer RNA-seq samples. |
| Q96302702 | Histology-agnostic drug development - considering issues beyond the tissue |
| Q46229973 | Identification of NTRK fusions in pediatric mesenchymal tumors |
| Q58080406 | Immunohistochemical Correlates of Recurrent Genetic Alterations in Sarcomas |
| Q37357286 | Infantile Fibrosarcoma With NTRK3-ETV6 Fusion Successfully Treated With the Tropomyosin-Related Kinase Inhibitor LOXO-101. |
| Q54117764 | Inhibiting TRK Proteins in Clinical Cancer Therapy. |
| Q89842057 | Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee |
| Q54958100 | Lipofibromatosis-like neural tumor: Case report of a unique infantile presentation. |
| Q54981810 | Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors. |
| Q51733074 | NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma. |
| Q52885342 | Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic/haemangiopericytic pattern. |
| Q38956444 | Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions |
| Q36350870 | Promoter hypermethylation as a mechanism for Lamin A/C silencing in a subset of neuroblastoma cells. |
| Q47649693 | Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma |
| Q48368768 | Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy. |
| Q41631541 | Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural Tumors |
| Q48151927 | Recurrent and metastatic congenital mesoblastic nephroma: where does the evidence stand? |
| Q55289701 | Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants. |
| Q64237933 | Refractory and metastatic infantile fibrosarcoma harboring fusion shows complete and durable response to crizotinib |
| Q98386647 | Successful treatment of lipofibromatosis-like neural tumor of the lumbar spine with an NTRK-fusion inhibitor |
| Q57815366 | Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors |
| Q57050736 | TRK Inhibition: A New Tumor-Agnostic Treatment Strategy |
| Q55422121 | The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII. |
Search more.